MabThera Filed in the EU for Treatment of Most Common Leukaemia in Adults
BASEL, Switzerland, July 31 /PRNewswire/ --
- Submission Based on Phase III Study Showing Superior Results for MabThera in Chronic Lymphocytic Leukaemia (CLL) When Added to Standard Chemotherapy…